Skip to main content
. 2024 Feb 8;35(1):123–133. doi: 10.31138/mjr.140223.sof

Table 6.

Side effects experienced from COVID-19 vaccine.

Side-effects after first and second dose Type of vaccinations Total No. (%)
Pfizer Sinopharm AstraZeneca
No. (%) No. (%) No. (%)
1st dose 2nddose 1st dose 2nd dose 1st dose 2nd dose 1st dose 2nd dose
Pain at site of injection 307(62.3) 204(52.3) 38(35.5) 24(29.7) 37(60.7) 25(44.6) 382(57.8) 253(47.9)
Fatigue 178(36.1) 154(39.5) 25(23.4) 13(15.1) 27(44.3) 23(41.1) 230(34.8) 190(35.9)
Fever 175(35.5) 133(34.1) 25(23.4) 9(10.5) 29(47.5) 12(21.4) 229(34.6) 154(28.9)
Headache 75(15.2) 0(0.0) 17(15.9) 6(7.0) 15(24.6) 11(19.6) 107(16.2) 17(3.2)
Myalgia 66(13.4) 63(16.2) 12(11.2) 8(9.3) 15(24.6) 9(16.1) 93(14.1) 80(15.2)
Chills 16(3.2) 11(2.8) 1(0.9) 2(2.3) 4(6.6) 1(1.8) 21(3.2) 14(2.6)
Arthralgia 4(0.8) 3(0.8) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 4(0.6) 3(0.6)
Nausea/vomiting 6(1.2) 8(2.1) 2(1.9) 0(0.0) 2(3.3) 0(0.0) 10(1.5) 8(1.5)
Elevated liver enzymes 1(0.2) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 1(0.2) 0(0.0)
Thrombosis 1(0.2) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 1(0.2) 0(0.0)
Vasculitis 1(0.2) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 1(0.2) 0(0.0)
Sore throat 1(0.2) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 1(0.2) 0(0.0)
Lymphadenopathy 1(0.2) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 1(0.2) 0(0.0)
Skin rash 0(0.0) 1(0.3) 1(0.9) 0(0.0) 0(0.0)0 0(0.0) 1(0.2) 1(0.2)
Flu like illness 0(0.0) 1(0.3) 1(0.9) 1(1.2) 0(0.0) 0(0.0) 1(0.2) 2(0.4)
Palpitation 0(0.0) 0 2(1.9) 0 0(0.0) 0(0.0) 2(0.3) 0(0.0)
Left shoulder pain 0(0.0) 0(0.0) 1(0.9) 1(1.2) 0(0.0) 0(0.0) 1(0.2) 1(0.2)
Cough 1(0.2) 2(0.5) 0(0.0) 0(0.0) 1(1.6) 0(0.0) 2(0.3) 2(0.4)
Chest pain 0(0.0) 0(0.0) 0(0.0) 0(0.0) 1(1.6) 0(0.0) 1(0.2) 0(0.0)
Dysphagia 0(0.0) 0(0.0) 0(0.0) 0(0.0) 1(1.6) 0(0.0) 1(0.2) 0(0.0)
Muscle weakness 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 1(1.8) 0(0.0) 1(0.2)
Total 493 390 107 86 61 56 661 528